Muhammed S.T. Kariapper
Roswell Park Cancer Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Muhammed S.T. Kariapper.
Technology in Cancer Research & Treatment | 2005
Mohamed K. Khan; Shraddha S. Nigavekar; Leah Minc; Muhammed S.T. Kariapper; Bindu M. Nair; Wojciech Lesniak; Lajos Balogh
Our results indicate that the surface chemistry, composition, and 3-D structure of nanoparticles are critical in determining their in vivo biodistribution, and therefore the efficacy of nanodevice imaging and therapies. We demonstrate that gold/dendrimer nanocomposites in vivo, present biodistribution characteristics different from PAMAM dendrimers in a B16 mouse tumor model system. We review important chemical and biologic uses of these nanodevices and discuss the potential of nanocomposite devices to greatly improve cancer imaging and therapy, in particular radiation therapy. We also discuss major issues confronting the use of nanoparticles in the near future, with consideration of toxicity analysis and whether biodegradable devices are needed or even desirable.
Nanotoxicology | 2009
Bindu M. Nair; Muhammed S.T. Kariapper; Wojciech Lesniak; Wei Tan; Alan D. Hutson; Mohamed K. Khan; Lajos Balogh
Composite nanodevices (CNDs) are a well-studied class of multifunctional nanomaterials with several potential medical uses, including cancer imaging and therapy. Gold/ dendrimer CNDs are organic/inorganic hybrid materials consisting of physical networks of dendrimer(s) and inorganic materials. This design permits properties of dendrimers and inorganic materials to be individually modified and optimized. A detailed understanding of factors regulating toxicity is lacking. We develop and test toxicity assays for CNDs in vitro both for cancer cells and for normal endothelial cells. We show how CND surface charge (positive, negative or neutral) and exposure time affects biosafety for d = 5 nm nanodevices. We also show that formation of the CND (incorporation of gold into a dendrimer template) can lower toxicity of a dendrimer. Interestingly, we also show that tumour cells and proliferating endothelial cells have different toxicity profiles.
Cancer Research | 2010
Muhammed S.T. Kariapper; Venugopalan Kasturirangan; Erin Tracy; Wei Tan; Imad A. Kariapper; Wojciech Lesniak; Heinz Baumann; Harry K. Slocum; Alan D. Hutson; Lajos Balogh; Mohamed K. Khan
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Background: The use of nanomaterials in biomedical applications is increasing exponentially, with multiple devices being explored for cancer imaging and therapy. For them to enter the clinic, however, it is very important that the toxicity as well as other effects on the tumor microenvironment is assessed accurately over time. In this study, we investigated the cell motility and the cell mitosis of proliferating human endothelial cells, critical components of the tumor microenvironment, while they are treated with PAMAM dendrimer nanoparticles using time-lapsed video microscopy. Conventional in vitro cytotoxicity assays give a cumulative result of the whole cell population whereas the time-lapsed video microscopy allows one to visualize continuously and analyze each cell separately for the cytotoxicity effect of the treatments. We also assess another critical component of the microenvironment, the “irritability” or inflammability of nanoparticles toward human lung macrophages using rocket immuno-electrophoresis, a powerful and quantitative immuno-analytical technique consists of a two-dimensional immunoelectrophoresis with a combination of conventional electrophoretic separation and electro-immunodiffusion. Purpose: Assessment of key tumor microenvironment in the cells exposed to PAMAM dendrimer nanoparticles Experimental: (a). HUVEC were treated with PAMAM generation-5 parent dendrimer nanoparticle and analyzed frame-by-frame using time-lapse video microscopy against the untreated cells. (b) Human lung macrophage cells were treated with PAMAM generation-5 dendrimers of different levels of surface positive charges or positive control turpentine. After 24 hours, the conditioned macrophage medium was added onto rat hepatoma cells. After 24 hours, the medium is removed and analyzed by rocket immunoelectrophoresis for inflammation markers, α1-acid glycoprotein and haptoglobin, two well known acute phase reactants whose levels in the serum increase following inflammatory stimuli. Results and Conclusions: (a) time-lapse video microscopy permitted the quantitative assessment of cell death and mitosis in treated and untreated endothelial cells. (b) In inflammation assays, fully positive surface-charged dendrimers, expected to have the most toxicity, were safe even at high physiologic concentrations (at or below 0.1 μM level) and did not exhibit any detectable toxicity (cell kill) or have any inflammatory effect on human lung macrophages in these concentrations. Neutralization of amino groups made these materials completely non-toxic, even at non-physiologic concentrations (1 μM) and none showed any significant inflammation effect compared to well known irritant turpentine, based on acute phase reactants α1-acid glycoprotein and haptoglobin levels whose levels in the serum increase following inflammatory stimuli. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2262.
Nanomedicine: Nanotechnology, Biology and Medicine | 2007
Lajos Balogh; Shraddha S. Nigavekar; Bindu M. Nair; Wojciech Lesniak; Chunxin Zhang; Lok Yun Sung; Muhammed S.T. Kariapper; Areej El-Jawahri; Mikel Llanes; Brian Bolton; Fatema Mamou; Wei Tan; Alan D. Hutson; Leah Minc; Mohamed K. Khan
Bioconjugate Chemistry | 2007
Wojciech Lesniak; Muhammed S.T. Kariapper; Bindu M. Nair; Wei Tan; Alan D. Hutson; Lajos Balogh; Mohamed K. Khan
Nanomedicine: Nanotechnology, Biology and Medicine | 2008
Mohamed K. Khan; Leah Minc; Shraddha S. Nigavekar; Muhammed S.T. Kariapper; Bindu M. Nair; Matthew Schipper; Andrew C. Cook; Wojciech Lesniak; Lajos Balogh
Pharmaceutical Research | 2012
Donald E. Mager; Vidhi Mody; Chao Xu; Alan Forrest; Wojciech Lesniak; Shraddha S. Nigavekar; Muhammed S.T. Kariapper; Leah Minc; Mohamed K. Khan; Lajos Balogh
Anticancer Research | 2006
Fatema Mamou; Kerstin S. May; Matthew Schipper; Navkiranjit K. Gill; Muhammed S.T. Kariapper; Bindu M. Nair; George J. Brewer; Daniel P. Normolle; Mohamed K. Khan
Archives of Otolaryngology-head & Neck Surgery | 2006
Mohamed K. Khan; Fatema Mamou; Matthew Schipper; Kerstin S. May; Alla Kwitny; Amber Warnat; Brian Bolton; Bindu M. Nair; Muhammed S.T. Kariapper; Meredith W. Miller; George J. Brewer; Daniel P. Normolle; Sofia D. Merajver; Theodoros N. Teknos
2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings | 2006
Lajos Balogh; Wojciech Lesniak; Vladimir A. Sinani; Anna U. Bielinska; Kai Sun; Bindu M. Nair; Emily Waite; Muhammed S.T. Kariapper; Mohamed K. Khan